Chief Scientific Officer - Early Drug Development

Job Description

About the Role

The Chief Scientific Officer - Early Drug Development will formulate and lead the company's global early-stage R&D strategy, establishing the R&D roadmap from target validation to proof-of-concept (POC).

Responsibilities

• Lead the drug chemistry team and the biology team.
• Establish a global R&D layout and talent echelon for innovative drugs of Qilu.
• Plan and make decisions regarding the innovative drug pipeline, including cutting-edge technology fields such as small molecules, large molecules, ADCs, and small nucleic acids.
• Establish strategic partnerships with the global academic community, research institutions, and biotechnology companies to introduce cutting-edge technologies.
• Research on leadership mechanisms and formulate biomarker strategies to provide a solid scientific basis for R&D decisions.

Qualifications

• Possess a doctoral degree in life sciences or a related medical field.
• Over 20 years of research and development experience in multinational pharmaceutical companies or top biotech firms.

Required Skills

• Profound biological knowledge in core disease areas such as oncology, metabolism, autoimmunity, or the central nervous system.
• Deep understanding of emerging therapeutic modalities.
• Complete R&D success experience from the laboratory to the clinic.
• Led and advanced at least five innovative drug projects into the clinical stage and successfully completed POC.
• Outstanding scientific insight and strategic decision-making ability to predict industry trends and transform them into the company's R&D advantages.
• Outstanding leadership with the charisma and influence to inspire, attract, and retain top scientific talents.

Preferred Skills

• Experience in establishing and managing global R&D teams.
• Strong network within the academic and biotechnology communities.

Pay range and compensation package

Competitive salary and comprehensive benefits package commensurate with experience.

首席科学官 - 早期药物研发

工作地点：美国波士顿、中国上海

工作职责：

• 制定并领导公司全球早期研发战略，确立从靶点验证到POC的概念验证的研发路线图。
• 统领药物化学团队、生物学团队，构建齐鲁创新药物全球研发布局与人才梯队。
• 主导创新药物管线的规划与决策，包括小分子、大分子、ADC、小核酸等前沿技术领域。
• 作为公司科学领域的最高代表，与全球学术界、研究机构及生物技术公司建立战略合作，引进前沿技术。
• 领导机制研究与生物标志物策略的制定，为研发决策提供坚实的科学依据。

任职要求：

• 拥有生命科学或医学相关领域的博士学位，20年以上在跨国药企或顶尖生物技术公司的研发经验。
• 具备深厚的肿瘤、代谢、自身免疫或中枢神经系统等核心疾病领域的生物学知识，并对新兴治疗模式有深刻理解。
• 拥有从实验室到临床的完整研发成功经验，曾主导推进至少5个创新药物项目进入临床阶段并成功完成POC。
• 卓越的科学洞察力与战略决策能力，能够预见行业趋势并转化为公司的研发优势。
• 出色的领导力，具备激发、吸引和保留顶尖科学人才的人格魅力与影响力。
• 具体岗位职级将根据候选人综合资质确定。